CHINA PHARMA HOLDINGS, INC. (12)
Browse by Contract Category
Contracts
-
Technology Transfer Contract, dated November 28, 2022, between Hainan Helpson Medical & Biotechnology Co., Ltd and Chengdu Bonier Medical Technology Development Co., Ltd
(Filed With SEC on December 2, 2022)
-
Loans Extension Confirmation Letter, dated December 31, 2021, between the Company and Heung Mei Tsui confirming the extension of the loans
(Filed With SEC on March 30, 2022)
-
Securities Purchase Agreement between China Pharma Holdings, Inc. and Streeterville Capital, LLC dated November 17, 2021
(Filed With SEC on November 23, 2021)
-
Form of Incentive Stock Option Grant Agreement
(Filed With SEC on September 15, 2021)
-
Description of Securities Registered Pursuant to Section 12 of the Exchange Act
(Filed With SEC on March 30, 2022)
-
Convertible Promissory Note dated November 17, 2021
(Filed With SEC on November 23, 2021)
-
Loans Extension Confirmation Letter, dated December 31, 2020, between the Company and Heung Mei Tsui confirming the extension of the loans
(Filed With SEC on March 26, 2021)
-
Loans Extension Confirmation Letter between the Company and Heung Mei Tsui confirming the extension of the loans
(Filed With SEC on March 30, 2020)
-
English translation of the Loan Agreement between the Company and Zhilin Li dated July 8, 2019
(Filed With SEC on August 14, 2019)
-
Offer Letter dated December 12, 2018 from the Company and accepted by Ms. Heung Mei Tsui for Ms. Tsui serving as a director of the Company
(Filed With SEC on March 28, 2019)
-
Offer Letter dated December 12, 2018 from the Company and accepted by Ms. Zhilin Li for Ms. Li serving as a director of the Company
(Filed With SEC on March 28, 2019)
-
Loans Extension Confirmation Letter between the Company and Heung Mei Tsui confirming the extension of the loans
(Filed With SEC on March 28, 2019)